The Latest in Thrombosis

Companies withheld info related to rivaroxaban trial, BMJ says

September 30, 2016

Thrombosis

Study sheds light on platelet disorders

September 30, 2016

Study: C-section increases risk of VTE

September 24, 2016

Thrombosis

EMA says plasma/urine-derived meds are safe from Zika

September 22, 2016

PAFC provides early embolus detection in mice

September 20, 2016

Thrombosis

FDA grants drug orphan designation for PNH

September 13, 2016

Bevacizumab no better than placebo for epistaxis in HHT

September 7, 2016

Saline comparable to drug therapy for epistaxis in HHT

September 7, 2016

FDA grants therapy orphan designation for hemophilia B

September 7, 2016

Thrombosis

Longer DAPT better for PAD, study suggests

September 3, 2016

Thrombosis

Edoxaban appears comparable to standard therapy

September 2, 2016

Thrombosis

Simple algorithm can rule out PE, team says

September 2, 2016

Thrombosis

Antidote to factor Xa inhibitors exhibits efficacy in patients with major bleeding

September 1, 2016

Thrombosis

Antiplatelet drugs comparable in patients with AMI

September 1, 2016

Thrombosis

Rule identifies women at low risk of VTE recurrence

August 31, 2016

Thrombosis